What is NCT04512345 studying?
NCT04512345 is a clinical trial registered on ClinicalTrials.gov that studies the use of tinidazole in a Phase 2 setting. The registration exists under the identifier NCT04512345 and is listed as a Phase 2 study involving tinidazole.
However, the specific disease/condition, treatment regimen, dosing schedule, inclusion criteria, primary endpoints, and current recruitment/locations are not included in the information provided here, so they can’t be stated accurately.
Where to find the trial’s exact condition, design, and endpoints
To get the exact details (condition being treated, study design, arms, dosing, enrollment status, and primary outcomes), the correct source is the ClinicalTrials.gov record for NCT04512345.
How can you check whether results are posted yet?
For NCT04512345, check the ClinicalTrials.gov page for:
- “Results Submitted” / “Results Posted” sections
- Any posted manuscripts or supplementary documents linked to the trial entry
- The “Last Update Posted” date (helps indicate whether the record has been refreshed)
If you want, I can summarize it precisely—share what you see
If you paste any of the following from the NCT04512345 page (or share the link text), I can summarize it into a clear Phase 2 “trial at a glance”:
- Condition
- Study type (randomized/controlled/open-label)
- Dose and schedule
- Enrollment size and status
- Primary endpoint(s)
- Key eligibility criteria
- Any outcome results if posted
Sources:
1. ClinicalTrials.gov search page for NCT04512345